Artiva Biotherapeutics, Inc. (ARTV) Reports Q3 Loss of $0.88
Tweet
Share
E-mailGet Alerts ARTV Hot Sheet
Join SI Premium – FREE
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) reported Q3 EPS of ($0.88).
For earnings history and earnings-related data on Artiva Biotherapeutics, Inc. (ARTV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Downgrades Monopar Therapeutics (MNPR) to Neutral
- Faraday Future stockholders approve $25M private placement proposal
- Goldman Sachs Upgrades Tingyi Cayman Islands Holding Corp. (322:HK) (TCYMY) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
